Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis

Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia.

Journal of clinical immunology·1996

Compound heterozygous protein C deficiency resulting in the presence of only the beta-form of protein C in plasma.

Blood·1996

Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraception.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1996

Inhibitory effect of prostacyclin and nitroprusside on type IIB von Willebrand factor-promoted platelet activation.

Thrombosis and haemostasis·1996

Deep venous thrombosis and lupus anticoagulant. A case-control study.

Thrombosis and haemostasis·1996

DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1996

A survey on the current clinical practices among obstetricians for the management of venous thromboembolism prevention in various hospitals in China.

Thrombosis research·2026

Polyendocrine metabolic ovarian syndrome and venous thromboembolism: Hemostatic considerations in diagnosis and management.

Thrombosis research·2026

Comparative validation of AHA/ACC 2026 and ESC 2019 risk stratification in hospitalized patients with acute pulmonary embolism.

Thrombosis research·2026

Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study.

Thrombosis research·2026

Tranexamic acid and its use in early pregnancy; a scoping review.

Thrombosis research·2026

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Thrombosis research·2026

Characterisation of the Novel HLA-A*32:207 Allele by Sequencing-Based Typing.

HLA·2026

Discovery of the Novel HLA-DQB1*05:386 Allele in a Brazilian Volunteer Donor.

HLA·2026

Identification of the Novel HLA-B*57:212 Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DRB3*01:127 Allele by Next-Generation Sequencing.

HLA·2026

Early-Onset TRNT1-Related SIFD Syndrome with an Additional Monoallelic C7 Variant: A Pediatric Case Report.

Diagnostics (Basel, Switzerland)·2026

Identification of the Novel HLA-DQB1*06:556 Allele by Next-Generation Sequencing.

HLA·2026

Related Experiment Videos

Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis

Related Concept Videos

Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia.

Compound heterozygous protein C deficiency resulting in the presence of only the beta-form of protein C in plasma.

Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraception.

Inhibitory effect of prostacyclin and nitroprusside on type IIB von Willebrand factor-promoted platelet activation.

Deep venous thrombosis and lupus anticoagulant. A case-control study.

DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.

A survey on the current clinical practices among obstetricians for the management of venous thromboembolism prevention in various hospitals in China.

Polyendocrine metabolic ovarian syndrome and venous thromboembolism: Hemostatic considerations in diagnosis and management.

Comparative validation of AHA/ACC 2026 and ESC 2019 risk stratification in hospitalized patients with acute pulmonary embolism.

Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study.

Tranexamic acid and its use in early pregnancy; a scoping review.

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Characterisation of the Novel HLA-A*32:207 Allele by Sequencing-Based Typing.

Discovery of the Novel HLA-DQB1*05:386 Allele in a Brazilian Volunteer Donor.

Identification of the Novel HLA-B*57:212 Allele by Next-Generation Sequencing.

Characterisation of the Novel HLA-DRB3*01:127 Allele by Next-Generation Sequencing.

Early-Onset TRNT1-Related SIFD Syndrome with an Additional Monoallelic C7 Variant: A Pediatric Case Report.

Identification of the Novel HLA-DQB1*06:556 Allele by Next-Generation Sequencing.

Related Experiment Videos

Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis

Related Concept Videos

Related Articles